Biotech startup BacAlt Biosciences has raised INR 18 crore in a funding round led by early-stage investor Avaana Capital. The round also saw participation from Lubrizol InnoVentures, the innovation arm of global specialty chemicals company Lubrizol.
With this investment company plans to use the funds to strengthen R&D, set up pilot production, hire more team members, and expand into new markets.
“Just getting rid of packaging or making your packaging recyclable or biodegradable is not good enough. We have to think about formulations. Almost 87% of the top 10 best-selling products contain microplastics in their formulations. That’s what we are changing,” founder and CEO Shruti Kutmutia said.
“We will commercially launch it in June next year, which is why we have raised this fund to set up a pre-pilot facility where our launch will truly take shape,” she added.
Shruti Srivastava, investment director at Avaana Capital, said, “By combining proprietary fermentation platforms with circular use of agricultural waste, BacAlt is delivering ingredients that meet the performance and cost thresholds required for scale in FMCG.”
“With Lubrizol’s expertise and global network and BacAlt’s pioneering bio-based polymers and speciality ingredients, we aim to accelerate the development of new products that deliver enhanced value to customers and positively impact global markets,” said John Patrin, managing director of Lubrizol InnoVentures.
BacAlt Biosciences was founded in 2023 by Shruti Kutmutia and Pranav Nair. The company is based in Bengaluru.
The startup creates sustainable specialty ingredients by using bio-manufacturing to turn agro-industrial waste into biopolymers.
The company makes sustainable, high-performance, and affordable ingredients for industries like home care, personal care, agrochemicals, nutraceuticals, and pharmaceuticals—offering an alternative to petrochemical and synthetic materials.
Its biopolymers are already being used in skincare, haircare, wound care, agriculture, and more.
